| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0042 | 0.9 |